◀ Back to IGF1
GRB2 — IGF1
Pathways - manually collected, often from reviews:
-
BioCarta multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation:
IGF-1/IGF-1/IGF-1R-alpha/IGF-1R-alpha/IGF-1R-beta/IGF-1R-beta/14-3-3 complex (IGF1R-YWHAH-IGF1)
→
SHC/GRB2/SOS-1 complex (SOS1-GRB2-SHC1)
(modification, activates)
-
BioCarta the igf-1 receptor and longevity:
IGF-1/IGF-1/IGF-1R-alpha/IGF-1R-alpha/IGF-1R-beta/IGF-1R-beta complex (IGF1-IGF1R)
→
SHC/GRB2/SOS-1 complex (SOS1-GRB2-SHC1)
(modification, activates)
-
BioCarta igf-1 signaling pathway:
IGF-1/IGF-1/IGF-1R-alpha/IGF-1R-alpha/IGF-1R-beta/IGF-1R-beta complex (IGF1-IGF1R)
→
SHC/GRB2/SOS-1 complex (SOS1-GRB2-SHC1)
(modification, activates)
-
BioCarta nfat and hypertrophy of the heart :
RAS activating ligand/RAS activating receptor complex (IGF1_HBEGF_LIF_ALOX15B_CTF1)
→
SHC/GRB2/SOS-1 complex (SOS1-GRB2-SHC1)
(modification, activates)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 complex (IGF1R-IGF1-IRS1-GNB2L1-GRB2-SHC1-SOS1)
→
PKC mu (PRKD1)
(modification, activates)
Hermanto et al., Mol Cell Biol 2002
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
→
HRAS/GTP complex (HRAS)
(modification, activates)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
→
HRAS/GDP complex (HRAS)
(modification, activates)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1 complex (IGF1R-IGF1-IRS1)
→
GRB2/SOS1 complex (GRB2-SOS1)
(modification, collaborate)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1 complex (IGF1R-IGF1-IRS1)
→
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos complex (IGF1R-IGF1-IRS1-GRB2-SOS1)
(modification, collaborate)
-
NCI Pathway Database IGF1 pathway:
GRB2/SOS1 complex (GRB2-SOS1)
→
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos complex (IGF1R-IGF1-IRS1-GRB2-SOS1)
(modification, collaborate)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
→
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 complex (IGF1R-IGF1-IRS1-GNB2L1-GRB2-SHC1-SOS1)
(modification, collaborate)
Hermanto et al., Mol Cell Biol 2002, Kiely et al., J Biol Chem 2005
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
→
RACK1 (GNB2L1)
(modification, collaborate)
Hermanto et al., Mol Cell Biol 2002, Kiely et al., J Biol Chem 2005
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 complex (IGF1R-IGF1-IRS1-GNB2L1-GRB2-SHC1-SOS1)
→
RACK1 (GNB2L1)
(modification, collaborate)
Hermanto et al., Mol Cell Biol 2002, Kiely et al., J Biol Chem 2005
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 complex (IGF1R-IGF1-IRS1-GNB2L1-GRB2-SHC1-SOS1)
→
PKC delta (PRKCD)
(modification, activates)
Hermanto et al., Mol Cell Biol 2002
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos complex (IGF1R-IGF1-IRS1-GRB2-SOS1)
→
HRAS/GDP complex (HRAS)
(modification, activates)
-
NCI Pathway Database IGF1 pathway:
GRB2/SOS1/SHC complex (GRB2-SOS1-SHC1)
→
IGF-1R heterotetramer/IGF1 complex (IGF1R-IGF1)
(modification, collaborate)
-
NCI Pathway Database IGF1 pathway:
GRB2/SOS1/SHC complex (GRB2-SOS1-SHC1)
→
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
(modification, collaborate)
-
NCI Pathway Database IGF1 pathway:
IGF-1R heterotetramer/IGF1 complex (IGF1R-IGF1)
→
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc complex (IGF1R-IGF1-GRB2-SHC1-SOS1)
(modification, collaborate)
Text-mined interactions from Literome
Ariga et al., Biochem J 2000
:
Under these conditions, cAMP pretreatment significantly increased binding of
Grb2 ( growth-factor-receptor bound protein 2 ) to Shc in
response to
IGF-I , and activation of MAP kinase ( mitogen activated protein kinase ) induced by IGF-I was also enhanced by cAMP
Mincione et al., Exp Cell Res 2003
:
Conversely, TGF-beta 1 did not alter
IGF-I stimulated IRS-1 associated phosphatidylinositol 3-kinase activity, IGF-I induced tyrosine phosphorylation of Shc, and its binding to
Grb2
Massicotte et al., Arthritis Res Ther 2006
(Osteoarthritis) :
The interaction of
Grb2 with IRS-1 progressively increased in
response to
IGF-1 in OA Obs whereas this was absent in normal Ob. IGF-1 stimulation altered alkaline phosphatase in Ob, an effect reduced in the presence of PD98059, an inhibitor of p42/44 MAPK signaling, whereas neither IGF-1 nor PD98059 had any significant effect on collagen synthesis
Shen et al., J Biol Chem 2010
:
A proline-rich sequence in PDK1 bound to an Src homology 3 domain in
Grb2 in
response to
IGF-I
Valverde et al., Mol Endocrinol 1998
:
Furthermore,
insulin/IGF-I stimulated IRS-1 associated
Grb-2 phosphorylation
Hügl et al., J Biol Chem 1998
:
Glucose and
IGF-I also
induced Shc association with
Grb2/mSOS
Kim et al., J Biol Chem 1998
(Neuroblastoma) :
In the current study, we report that
IGF-I induces a sustained tyrosine phosphorylation of Shc and its association with
Grb2 in SH-SY5Y human neuroblastoma cells ... In contrast,
IGF-I induces a transient tyrosine phosphorylation of IRS-2 and an association of IRS-2 with
Grb2 ... In contrast,
IGF-I induces a transient tyrosine phosphorylation of IRS-2 and an association of IRS-2 with
Grb2